Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03833583 · ClinicalTrials.gov registry record · NA
TDCS for Cocaine Addiction Craving
A NA study, sponsored by Soterix Medical.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03833583: Completed NA study, sponsored by Soterix Medical.
NCT03833583 is a NA study that has completed, run by Soterix Medical. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03833583, a NA study, has completed, sponsored by Soterix Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation in which low level electrical currents are applied to the scalp in order to alter brain function. In the present study, tDCS will be administered with the goal of assessing the tolerability and feasibility of this approach to 1) reduce an individual's level of drug craving and 2) provide evidence to support the use of this device by the patient for future unsupervised stimulation in a non-clinical setting. Research Questions: * Can tDCS be used successfully to train cocaine addicted individuals for self-administration purposes? * Can active tDCS be used to decrease drug craving in individuals with cocaine use disorders? * Does active tDCS outperform sham tDCS in reducing drug craving?
Primary Outcome
Craving for cocaine will be assessed with a brief scale composed of 5 items (1, 2, 4, 5, and 13) from the Obsessive-Compulsive Cocaine Scale (OCCS; Vorspan et al., 2012).
Interventions
- DEVICE Soterix Medical mini-CT tDCS stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2019-09-30 |
| Phase | NA |
What the finished NCT03833583 record still lists
NCT03833583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Soterix Medical mini-CT tDCS stimulator is the first listed.
NCT03833583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03833583 about?
NCT03833583 is a clinical study titled "TDCS for Cocaine Addiction Craving". Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation in which low level electrical currents are applied to the scalp in order to alter brain function. In the present study, tDCS will be administered with the goal of assessing the tolerability and feasibility of ...
What is the current status of trial NCT03833583?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-02-01. Estimated completion is 2019-09-30.
What interventions are being tested in trial NCT03833583?
The interventions under investigation include: Soterix Medical mini-CT tDCS stimulator (DEVICE).
Who is sponsoring clinical trial NCT03833583?
This trial is sponsored by Soterix Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03833583's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI